Physician reimbursement remains a central stress point in the broader outpatient surgery narrative. After adjusting for inflation and practice costs, Medicare physician payments are widely acknowledged to have declined by approximately 30 % since the early 2000s, while facility and hospital-based payments have risen substantially over the same period.

This long-term squeeze has generated persistent political tension, repeated legislative threats of across-the-board fee reductions, and periodic ad hoc congressional interventions to avert cuts.

Against this backdrop, many surgeons and physician practices are increasingly motivated to shift all eligible procedures into physician-owned ambulatory settings, where they can capture facility-side revenue that otherwise accrues to hospitals. Estimates from national market reports suggest that for surgeons transferring just 30–40 % of appropriate cases into ASCs, reimbursable facility revenue can exceed tens or even hundreds of thousands of dollars annually.

This economic reality—physicians reclaiming value by strategically migrating care—has become a core driver of outpatient growth, outpacing purely clinical or technological rationales in some specialties.